Effect of nos inhibition on rat gastric matrix metalloproteinase production during endotoxemia

Matrix metalloproteinases (MMPs) degrade the extracellular matrix and contribute to LPS-induced gastric injury. MMPs are closely modulated by their activators, membrane type-MMP (MT-MMPs) and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). As LPS-induced gastric inj...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Shock (Augusta, Ga.) Ga.), 2006-05, Vol.25 (5), p.507-514
Hauptverfasser: ROBINSON, Emily K, SEAWORTH, Christine M, SULIBURK, James W, ADAMS, Sasha D, KAO, Lillian S, MERCER, David W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 514
container_issue 5
container_start_page 507
container_title Shock (Augusta, Ga.)
container_volume 25
creator ROBINSON, Emily K
SEAWORTH, Christine M
SULIBURK, James W
ADAMS, Sasha D
KAO, Lillian S
MERCER, David W
description Matrix metalloproteinases (MMPs) degrade the extracellular matrix and contribute to LPS-induced gastric injury. MMPs are closely modulated by their activators, membrane type-MMP (MT-MMPs) and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). As LPS-induced gastric injury is mediated in part by iNOS, and NO modulates MMP production in vitro, we hypothesized that NOS inhibition would similarly modulate LPS-induced gastric MMP production. Therefore, the purpose of these studies was to compare the effects of selective and nonselective NOS inhibition on LPS-induced gastric MMP production. Sprague-Dawley rats were given either the nonselective NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 5 mg/kg, s.c.), a selective iNOS inhibitor, aminoguanidine (45 mg/kg, i.p.) or L-N-iminoethyl-lysine (L-NIL; 10 mg/kg, i.p.), or vehicle 15 min before saline or LPS (20 mg/kg, i.p.) and killed 24 h after LPS administration. Stomachs were assessed for macroscopic injury (computed planimetry), and gastric mucosal MMP production was assessed by gelatin zymography, in situ zymography, and Western analysis for MMP-2, MT1-MMP, and TIMP-2. (n > or = 4/group; ANOVA). Aminoguanidine treatment decreased LPS-induced macroscopic gastric injury as well as MMP-2 and MT1-MMP protein production while having no effect on TIMP-2 protein levels. L-NIL similarly attenuated the induction of MMP-2 and MT1-MMP by LPS. L-NAME failed to attenuate LPS induced gastric injury or MT1-MMP protein induction and increased MMP-2 levels. L-NAME similarly had no effect on gastric TIMP-2 production. Selective iNOS inhibition decreases gastric MMP-2 activity after LPS administration, whereas nonselective inhibition increases MMP-2 levels. The ability of selective iNOS inhibition to ameliorate LPS-induced gastric injury may be due in part to its inhibition of active MMP-2 production, whereas nonselective NOS inhibitors increase MMP-2 levels and maintain gastric injury after LPS administration.
doi_str_mv 10.1097/01.shk.0000209543.83929.bd
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67946098</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67946098</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-b28cc063ce35341bf22f311045f955f20d74b0391822a2831a6b77ab3244ee973</originalsourceid><addsrcrecordid>eNpFkFtLHjEQhoMoam3_ggTB3u06OWyy6V0RewChN-1tQ5JNNLq70SQL9t836gffEJi5eN7J8CB0QaAnoOQVkL7cP_bQioIaOOtHpqjq7XSATsnAoYOB8MM2g2QdZZSeoA-lPDScMyWP0QkRYgQg4hT9vQnBu4pTwGsqOK730cYa04rby6biO1Nqjg4vprUXvPhq5jk95VR9XE3xuI3T5t4i05bjeof9OqWaXvwSzUd0FMxc_KddP0N_vt38vv7R3f76_vP6623nmFK1s3R0DgRzng2MExsoDYwQ4ENQwxAoTJJbYIqMlBo6MmKEldJYRjn3Xkl2hj6_723XPG--VL3E4vw8m9WnrWghFRegxgZ-eQddTqVkH_RTjovJ_zQB_WpXA9HNrt7b1W92tZ1a-Hz3y2YXP-2jO50NuNwBpjgzh2xWF8uek1KIoZ37HzGthUw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67946098</pqid></control><display><type>article</type><title>Effect of nos inhibition on rat gastric matrix metalloproteinase production during endotoxemia</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>ROBINSON, Emily K ; SEAWORTH, Christine M ; SULIBURK, James W ; ADAMS, Sasha D ; KAO, Lillian S ; MERCER, David W</creator><creatorcontrib>ROBINSON, Emily K ; SEAWORTH, Christine M ; SULIBURK, James W ; ADAMS, Sasha D ; KAO, Lillian S ; MERCER, David W</creatorcontrib><description>Matrix metalloproteinases (MMPs) degrade the extracellular matrix and contribute to LPS-induced gastric injury. MMPs are closely modulated by their activators, membrane type-MMP (MT-MMPs) and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). As LPS-induced gastric injury is mediated in part by iNOS, and NO modulates MMP production in vitro, we hypothesized that NOS inhibition would similarly modulate LPS-induced gastric MMP production. Therefore, the purpose of these studies was to compare the effects of selective and nonselective NOS inhibition on LPS-induced gastric MMP production. Sprague-Dawley rats were given either the nonselective NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 5 mg/kg, s.c.), a selective iNOS inhibitor, aminoguanidine (45 mg/kg, i.p.) or L-N-iminoethyl-lysine (L-NIL; 10 mg/kg, i.p.), or vehicle 15 min before saline or LPS (20 mg/kg, i.p.) and killed 24 h after LPS administration. Stomachs were assessed for macroscopic injury (computed planimetry), and gastric mucosal MMP production was assessed by gelatin zymography, in situ zymography, and Western analysis for MMP-2, MT1-MMP, and TIMP-2. (n &gt; or = 4/group; ANOVA). Aminoguanidine treatment decreased LPS-induced macroscopic gastric injury as well as MMP-2 and MT1-MMP protein production while having no effect on TIMP-2 protein levels. L-NIL similarly attenuated the induction of MMP-2 and MT1-MMP by LPS. L-NAME failed to attenuate LPS induced gastric injury or MT1-MMP protein induction and increased MMP-2 levels. L-NAME similarly had no effect on gastric TIMP-2 production. Selective iNOS inhibition decreases gastric MMP-2 activity after LPS administration, whereas nonselective inhibition increases MMP-2 levels. The ability of selective iNOS inhibition to ameliorate LPS-induced gastric injury may be due in part to its inhibition of active MMP-2 production, whereas nonselective NOS inhibitors increase MMP-2 levels and maintain gastric injury after LPS administration.</description><identifier>ISSN: 1073-2322</identifier><identifier>EISSN: 1540-0514</identifier><identifier>DOI: 10.1097/01.shk.0000209543.83929.bd</identifier><identifier>PMID: 16680016</identifier><language>eng</language><publisher>Augusta, GA: BioMedical Press</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Biological and medical sciences ; Blood. Blood coagulation. Reticuloendothelial system ; Endotoxemia - metabolism ; Enzyme Inhibitors - pharmacology ; Extracellular Matrix - metabolism ; Feeding. Feeding behavior ; Female ; Fundamental and applied biological sciences. Psychology ; Gastric Mucosa - enzymology ; Gelatinases - metabolism ; Intensive care medicine ; Lipopolysaccharides - chemistry ; Lipopolysaccharides - metabolism ; Matrix Metalloproteinase 2 - biosynthesis ; Matrix Metalloproteinase 2 - chemistry ; Medical sciences ; Models, Biological ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitric Oxide Synthase Type II - antagonists &amp; inhibitors ; Nitric Oxide Synthase Type II - metabolism ; Pharmacology. Drug treatments ; Rats ; Rats, Sprague-Dawley ; Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><ispartof>Shock (Augusta, Ga.), 2006-05, Vol.25 (5), p.507-514</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-b28cc063ce35341bf22f311045f955f20d74b0391822a2831a6b77ab3244ee973</citedby><cites>FETCH-LOGICAL-c399t-b28cc063ce35341bf22f311045f955f20d74b0391822a2831a6b77ab3244ee973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17766597$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16680016$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ROBINSON, Emily K</creatorcontrib><creatorcontrib>SEAWORTH, Christine M</creatorcontrib><creatorcontrib>SULIBURK, James W</creatorcontrib><creatorcontrib>ADAMS, Sasha D</creatorcontrib><creatorcontrib>KAO, Lillian S</creatorcontrib><creatorcontrib>MERCER, David W</creatorcontrib><title>Effect of nos inhibition on rat gastric matrix metalloproteinase production during endotoxemia</title><title>Shock (Augusta, Ga.)</title><addtitle>Shock</addtitle><description>Matrix metalloproteinases (MMPs) degrade the extracellular matrix and contribute to LPS-induced gastric injury. MMPs are closely modulated by their activators, membrane type-MMP (MT-MMPs) and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). As LPS-induced gastric injury is mediated in part by iNOS, and NO modulates MMP production in vitro, we hypothesized that NOS inhibition would similarly modulate LPS-induced gastric MMP production. Therefore, the purpose of these studies was to compare the effects of selective and nonselective NOS inhibition on LPS-induced gastric MMP production. Sprague-Dawley rats were given either the nonselective NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 5 mg/kg, s.c.), a selective iNOS inhibitor, aminoguanidine (45 mg/kg, i.p.) or L-N-iminoethyl-lysine (L-NIL; 10 mg/kg, i.p.), or vehicle 15 min before saline or LPS (20 mg/kg, i.p.) and killed 24 h after LPS administration. Stomachs were assessed for macroscopic injury (computed planimetry), and gastric mucosal MMP production was assessed by gelatin zymography, in situ zymography, and Western analysis for MMP-2, MT1-MMP, and TIMP-2. (n &gt; or = 4/group; ANOVA). Aminoguanidine treatment decreased LPS-induced macroscopic gastric injury as well as MMP-2 and MT1-MMP protein production while having no effect on TIMP-2 protein levels. L-NIL similarly attenuated the induction of MMP-2 and MT1-MMP by LPS. L-NAME failed to attenuate LPS induced gastric injury or MT1-MMP protein induction and increased MMP-2 levels. L-NAME similarly had no effect on gastric TIMP-2 production. Selective iNOS inhibition decreases gastric MMP-2 activity after LPS administration, whereas nonselective inhibition increases MMP-2 levels. The ability of selective iNOS inhibition to ameliorate LPS-induced gastric injury may be due in part to its inhibition of active MMP-2 production, whereas nonselective NOS inhibitors increase MMP-2 levels and maintain gastric injury after LPS administration.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blood. Blood coagulation. Reticuloendothelial system</subject><subject>Endotoxemia - metabolism</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Extracellular Matrix - metabolism</subject><subject>Feeding. Feeding behavior</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gastric Mucosa - enzymology</subject><subject>Gelatinases - metabolism</subject><subject>Intensive care medicine</subject><subject>Lipopolysaccharides - chemistry</subject><subject>Lipopolysaccharides - metabolism</subject><subject>Matrix Metalloproteinase 2 - biosynthesis</subject><subject>Matrix Metalloproteinase 2 - chemistry</subject><subject>Medical sciences</subject><subject>Models, Biological</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitric Oxide Synthase Type II - antagonists &amp; inhibitors</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><issn>1073-2322</issn><issn>1540-0514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkFtLHjEQhoMoam3_ggTB3u06OWyy6V0RewChN-1tQ5JNNLq70SQL9t836gffEJi5eN7J8CB0QaAnoOQVkL7cP_bQioIaOOtHpqjq7XSATsnAoYOB8MM2g2QdZZSeoA-lPDScMyWP0QkRYgQg4hT9vQnBu4pTwGsqOK730cYa04rby6biO1Nqjg4vprUXvPhq5jk95VR9XE3xuI3T5t4i05bjeof9OqWaXvwSzUd0FMxc_KddP0N_vt38vv7R3f76_vP6623nmFK1s3R0DgRzng2MExsoDYwQ4ENQwxAoTJJbYIqMlBo6MmKEldJYRjn3Xkl2hj6_723XPG--VL3E4vw8m9WnrWghFRegxgZ-eQddTqVkH_RTjovJ_zQB_WpXA9HNrt7b1W92tZ1a-Hz3y2YXP-2jO50NuNwBpjgzh2xWF8uek1KIoZ37HzGthUw</recordid><startdate>20060501</startdate><enddate>20060501</enddate><creator>ROBINSON, Emily K</creator><creator>SEAWORTH, Christine M</creator><creator>SULIBURK, James W</creator><creator>ADAMS, Sasha D</creator><creator>KAO, Lillian S</creator><creator>MERCER, David W</creator><general>BioMedical Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060501</creationdate><title>Effect of nos inhibition on rat gastric matrix metalloproteinase production during endotoxemia</title><author>ROBINSON, Emily K ; SEAWORTH, Christine M ; SULIBURK, James W ; ADAMS, Sasha D ; KAO, Lillian S ; MERCER, David W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-b28cc063ce35341bf22f311045f955f20d74b0391822a2831a6b77ab3244ee973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blood. Blood coagulation. Reticuloendothelial system</topic><topic>Endotoxemia - metabolism</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Extracellular Matrix - metabolism</topic><topic>Feeding. Feeding behavior</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gastric Mucosa - enzymology</topic><topic>Gelatinases - metabolism</topic><topic>Intensive care medicine</topic><topic>Lipopolysaccharides - chemistry</topic><topic>Lipopolysaccharides - metabolism</topic><topic>Matrix Metalloproteinase 2 - biosynthesis</topic><topic>Matrix Metalloproteinase 2 - chemistry</topic><topic>Medical sciences</topic><topic>Models, Biological</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitric Oxide Synthase Type II - antagonists &amp; inhibitors</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ROBINSON, Emily K</creatorcontrib><creatorcontrib>SEAWORTH, Christine M</creatorcontrib><creatorcontrib>SULIBURK, James W</creatorcontrib><creatorcontrib>ADAMS, Sasha D</creatorcontrib><creatorcontrib>KAO, Lillian S</creatorcontrib><creatorcontrib>MERCER, David W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Shock (Augusta, Ga.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ROBINSON, Emily K</au><au>SEAWORTH, Christine M</au><au>SULIBURK, James W</au><au>ADAMS, Sasha D</au><au>KAO, Lillian S</au><au>MERCER, David W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of nos inhibition on rat gastric matrix metalloproteinase production during endotoxemia</atitle><jtitle>Shock (Augusta, Ga.)</jtitle><addtitle>Shock</addtitle><date>2006-05-01</date><risdate>2006</risdate><volume>25</volume><issue>5</issue><spage>507</spage><epage>514</epage><pages>507-514</pages><issn>1073-2322</issn><eissn>1540-0514</eissn><abstract>Matrix metalloproteinases (MMPs) degrade the extracellular matrix and contribute to LPS-induced gastric injury. MMPs are closely modulated by their activators, membrane type-MMP (MT-MMPs) and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). As LPS-induced gastric injury is mediated in part by iNOS, and NO modulates MMP production in vitro, we hypothesized that NOS inhibition would similarly modulate LPS-induced gastric MMP production. Therefore, the purpose of these studies was to compare the effects of selective and nonselective NOS inhibition on LPS-induced gastric MMP production. Sprague-Dawley rats were given either the nonselective NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 5 mg/kg, s.c.), a selective iNOS inhibitor, aminoguanidine (45 mg/kg, i.p.) or L-N-iminoethyl-lysine (L-NIL; 10 mg/kg, i.p.), or vehicle 15 min before saline or LPS (20 mg/kg, i.p.) and killed 24 h after LPS administration. Stomachs were assessed for macroscopic injury (computed planimetry), and gastric mucosal MMP production was assessed by gelatin zymography, in situ zymography, and Western analysis for MMP-2, MT1-MMP, and TIMP-2. (n &gt; or = 4/group; ANOVA). Aminoguanidine treatment decreased LPS-induced macroscopic gastric injury as well as MMP-2 and MT1-MMP protein production while having no effect on TIMP-2 protein levels. L-NIL similarly attenuated the induction of MMP-2 and MT1-MMP by LPS. L-NAME failed to attenuate LPS induced gastric injury or MT1-MMP protein induction and increased MMP-2 levels. L-NAME similarly had no effect on gastric TIMP-2 production. Selective iNOS inhibition decreases gastric MMP-2 activity after LPS administration, whereas nonselective inhibition increases MMP-2 levels. The ability of selective iNOS inhibition to ameliorate LPS-induced gastric injury may be due in part to its inhibition of active MMP-2 production, whereas nonselective NOS inhibitors increase MMP-2 levels and maintain gastric injury after LPS administration.</abstract><cop>Augusta, GA</cop><pub>BioMedical Press</pub><pmid>16680016</pmid><doi>10.1097/01.shk.0000209543.83929.bd</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1073-2322
ispartof Shock (Augusta, Ga.), 2006-05, Vol.25 (5), p.507-514
issn 1073-2322
1540-0514
language eng
recordid cdi_proquest_miscellaneous_67946098
source MEDLINE; Journals@Ovid LWW Legacy Archive; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals
subjects Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Biological and medical sciences
Blood. Blood coagulation. Reticuloendothelial system
Endotoxemia - metabolism
Enzyme Inhibitors - pharmacology
Extracellular Matrix - metabolism
Feeding. Feeding behavior
Female
Fundamental and applied biological sciences. Psychology
Gastric Mucosa - enzymology
Gelatinases - metabolism
Intensive care medicine
Lipopolysaccharides - chemistry
Lipopolysaccharides - metabolism
Matrix Metalloproteinase 2 - biosynthesis
Matrix Metalloproteinase 2 - chemistry
Medical sciences
Models, Biological
NG-Nitroarginine Methyl Ester - pharmacology
Nitric Oxide Synthase Type II - antagonists & inhibitors
Nitric Oxide Synthase Type II - metabolism
Pharmacology. Drug treatments
Rats
Rats, Sprague-Dawley
Vertebrates: anatomy and physiology, studies on body, several organs or systems
title Effect of nos inhibition on rat gastric matrix metalloproteinase production during endotoxemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T02%3A19%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20nos%20inhibition%20on%20rat%20gastric%20matrix%20metalloproteinase%20production%20during%20endotoxemia&rft.jtitle=Shock%20(Augusta,%20Ga.)&rft.au=ROBINSON,%20Emily%20K&rft.date=2006-05-01&rft.volume=25&rft.issue=5&rft.spage=507&rft.epage=514&rft.pages=507-514&rft.issn=1073-2322&rft.eissn=1540-0514&rft_id=info:doi/10.1097/01.shk.0000209543.83929.bd&rft_dat=%3Cproquest_cross%3E67946098%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67946098&rft_id=info:pmid/16680016&rfr_iscdi=true